PUNCTURE DEVICES, AND SYSTEMS AND METHODS FOR ACCESSING TISSUE

    公开(公告)号:US20190255285A1

    公开(公告)日:2019-08-22

    申请号:US16279536

    申请日:2019-02-19

    Abstract: Tissue puncture devices, and systems and methods for accessing tissue (e.g., cardiovascular tissue) according to the present disclosure may include a tubular sheath extending along a longitudinal axis, the tubular sheath having a proximal end and a distal end, a needle disposed coaxially in the sheath, the needle having a proximal end and a distal end and being movable along the longitudinal axis of sheath, and a needle control mechanism disposed at the proximal end of the needle, the needle control mechanism being configured to lock the distal end of the needle in a first position retracted within the distal end of the sheath, and release the needle to an unlocked second position such that the distal end of the needle is extendable beyond the distal end of the sheath.

    EMBOLIC PROTECTION DEVICE
    36.
    发明申请

    公开(公告)号:US20180206970A1

    公开(公告)日:2018-07-26

    申请号:US15821192

    申请日:2017-11-22

    CPC classification number: A61F2/01 A61F2/013 A61F2220/0008

    Abstract: An aortic arch embolic protection device may include an anchoring structure including a first anchoring ring at an upstream end and a second anchoring ring at a downstream end. A first filter element may extend from the first anchoring ring to the second anchoring ring and define a lumen through the aortic arch embolic protection device. A second filter element may be disposed within the lumen of the first filter element, wherein the second filter element includes an access port configured to facilitate passage of an interventional catheter through the access port. The anchoring structure may include a tubular scaffold extending from the first anchoring ring to the second anchoring ring. The second filter element may extend from the second anchoring ring upstream to the access port. The second filter element may extend transversely across the lumen of the first filter element at a plurality of axial locations.

    HEART VALVE REGURGITATION ANCHOR AND DELIVERY TOOL

    公开(公告)号:US20180049874A1

    公开(公告)日:2018-02-22

    申请号:US15678327

    申请日:2017-08-16

    Abstract: A heart valve anchor apparatus may include a body having a proximal portion and a distal portion. The body may include a first radially expandable portion at the proximal portion of the body, a second radially expandable portion at the distal portion of the body, and a root portion extending from the first radially expandable portion to the second radially expandable portion, the root portion having an outer extent. The first radially expandable portion may be configured to self-expand to an outer extent greater than the outer extent of the root portion when radially unconstrained. The second radially expandable portion may be configured to self-expand to an outer extent greater than the outer extent of the root portion when radially unconstrained. In an unstressed configuration, the body may define a longitudinal centerline that extends away from a plane tangent to the root portion.

    Edge to edge repair device for valves

    公开(公告)号:US12208008B2

    公开(公告)日:2025-01-28

    申请号:US17115032

    申请日:2020-12-08

    Abstract: A valve fixation device may comprise a unitary elongate member that is biased towards a closed configuration wherein at least a pair of tissue engaging surfaces of the elongate member are held adjacent to each other by a bias force. The bias force is at least equal to a valve leaflet grasping force, enabling the fixation device to grasp and retain leaflets as part of cardiac treatment. A delivery tool including a spreader may independently translate the tissue engaging surfaces to enable cardiac leaflets to be captured and retained by and/or between the tissue engaging surfaces. The valve fixation device may include at least two arms, each of which may be independently controlled to grasp and capture opposing leaflets of a valve, such as the anterior and posterior leaflets of a mitral valve, to reduce the size of the valve opening and improve cardiac performance.

Patent Agency Ranking